Details

Autor(en) / Beteiligte

• Popa, Miruna A
• Bourier, Felix
• Lengauer, Sarah
• Krafft, Hannah
• Bahlke, Fabian
• Förschner, Leonie V
• Dorfmeister, Stephan
• Kathan, Susanne
• Telishevska, Marta
• Englert, Florian
• Lennerz, Carsten
• Reents, Tilko
• Hessling, Gabriele
• Deisenhofer, Isabel
• Kottmaier, Marc

Titel

Safety profile and long-term efficacy of very high-power short-duration (60-70 W) catheter ablation for atrial fibrillation: results of a large comparative analysis

Ist Teil von

• Europace (London, England), 2023-02, Vol.25 (2), p.408-416

Ort / Verlag

England: Oxford University Press

Erscheinungsjahr

2023

Quelle

Electronic Journals Library

Beschreibungen/Notizen

• This retrospective study sought to compare complication rates and efficacy of power-controlled very high-power short-duration (vHPSD) and conventional catheter ablation in a large cohort of patients with atrial fibrillation (AF). We analyzed 1115 consecutive patients with AF (38.7% paroxysmal, 61.3% persistent) who received first-time catheter ablation at our centre from 2015 to 2021. Circumferential pulmonary vein isolation ± additional substrate ablation using an irrigated-tip catheter was performed with vHPSD (70 W/5-7 s or 60 W/7-10 s) in 574 patients and with conventional power (30-35 W/15-30 s) in 541 patients. Baseline characteristics were well-balanced between groups (mean age 65.1 ± 11.2 years, 63.4% male). The 30-day incidence of cardiac tamponade [2/574 (0.35%) vs. 1/541 (0.18%), P = 0.598], pericardial effusion ≥ 10 mm [2/574 (0.35%) vs. 1/541 (0.18%), P = 0.598] and transient ischaemic attack [1/574 (0.17%) vs. 2/541 (0.37%), P = 0.529] was not significantly different between vHPSD and conventional ablation. No stroke, atrio-esophageal fistula, cardiac arrest or death occurred. Procedure (122.2 ± 46.8 min vs. 155.0 ± 50.5 min, P < 0.001), radiofrequency (22.4 ± 19.3 min vs. 52.9 ± 22.0 min, P < 0.001), and fluoroscopy (8.1 ± 7.2 vs. 9.2 ± 7.4, P = 0.016) duration were significantly shorter in the vHPSD group. At 12 months follow-up, freedom of any atrial arrhythmia was 44.1% vs. 34.2% (P = 0.010) in persistent AF and 78.1% vs. 70.2% in paroxysmal AF (P = 0.068). vHPSD ablation is as safe as conventional ablation and is associated with an improved long-term efficacy in persistent AF.